TONG REN TANG1666.HKValuation Analysis
Based on the blended 10-year P/E and P/B percentiles, the stock currently sits in the “Deeply Undervalued” zone.
As of Oct 16, 2026, TONG REN TANG (1666.HK) trades at a P/E of 11.10x, P/B of 0.47x, P/S of 0.60x, and a dividend yield of 6.66%.
Longitudinal percentile comparison: P/E sits at the 20th percentile over the trailing 10Y window (vs. 48th percentile over 3Y); P/B sits at the 1st percentile over the trailing 10Y window (vs. 3rd percentile over 3Y); P/S sits at the 2nd percentile over the trailing 10Y window (vs. 8th percentile over 3Y).
Cross-sectional valuation: its P/E ranks at the 86th percentile within its industry and the 51st percentile across the broader market.
Shareholder return highlight: Total Shareholder Yield is 6.66%, ranking at the 97th percentile over the trailing 20Y window.
The P/E and P/B percentiles diverge here, differing by 18.5 points — relying on either metric alone could be misleading. Relative to the broader market, its P/E shows a deeper discount than it does against industry peers. Shareholder returns here are driven almost entirely by cash dividends, with minimal contribution from buybacks. TONG REN TANG operates in the Traditional Chinese Medicine Production sector. Data refreshes weekly and is for reference only, not investment advice.
Also listed as: HKG: 1666 · SEHK: 1666 · 1666
Want the full picture on whether TONG REN TANG (1666.HK) is under- or over-valued? See the full 3Y / 5Y / 10Y / 20Y P/E, P/B, P/S, Dividend Yield & Total Shareholder Yield percentile matrix and the interactive ECharts trend chart on this page.
Historical Percentiles by Metric
| Metric | Current | Market Percentile | Industry Percentile | 3Y Pctl | 5Y Pctl | 10Y Pctl | 20Y Pctl |
|---|---|---|---|---|---|---|---|
| P/E (TTM) | 11.10 | ||||||
| P/B (MRQ) | 0.47 | ||||||
| P/S (TTM) | 0.60 | ||||||
| Dividend Yield | 6.66% | ||||||
| Buyback + Div Yield | 6.66% |